BCR and prostate carcinoma: With these premises, we performed a systematic review and meta-analysis of the currently available studies to comprehensively explore the effects of metformin on both cancer prevention and the treatment outcomes of prostate cancer, specifically, its preventative qualities in regard to cancer risk and on its BCR as well as the all-cause mortality for the treatment outcomes of prostate cancer.